Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jan;52(1):47–53. doi: 10.1136/jcp.52.1.47

Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.

C J Darroch 1, R M Barnes 1, J Dawson 1
PMCID: PMC501007  PMID: 10343612

Abstract

AIM: To measure circulating antibodies to yeast organisms that could be used to characterise the yeast specific immune response in gastrointestinal disease. METHODS: A quantitative, isotype specific enzyme linked immunosorbent assay was developed to measure circulating antibodies to an aqueous extract of Saccharomyces cerevisiae (sacc). Comparisons of specific antibody concentrations were made between 224 healthy controls and 51 patients with Crohn's disease, 41 with ulcerative colitis, 24 with indeterminate colitis, 23 with chronic liver disease, 17 with coeliac disease, and seven with irritable bowel syndrome. Additional comparisons were made between Crohn's disease and ulcerative colitis patients. Within the Crohn's disease group, the dependence of antibody levels on several clinical variables was assessed. RESULTS: IgG and IgA anti-sacc antibodies were significantly raised in Crohn's disease. IgG antibodies were also raised in patients with chronic liver disease. Among patients with Crohn's disease, IgG antibody concentrations were higher in those with serum alpha 1 acid glycoprotein (AAG) above the normal range and there was a strong trend towards increased IgG anti-sacc in the presence of small bowel disease, whereas IgA anti-sacc correlated positively with disease duration. No differences were detected according to whether patients were taking steroids. Neither the Crohn's disease nor the chronic liver disease group differed from normal subjects in respect of IgG antibodies to bovine milk casein. On linear regression analysis of complete data from 39 Crohn's disease patients, AAG was found to be a significant predictor of both IgG and IgA antibodies, and male sex and disease duration to be additional predictors of IgA antibodies. There was a significant difference in IgG antibodies between Crohn's disease and ulcerative colitis. CONCLUSIONS: Raised antibodies to yeast, although not completely specific for Crohn's disease, may have a future role in diagnosis. The assays described here could be used to address this question in the context of a prospective study.

Full text

PDF
47

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André F., Druguet M., André C. Effect of food intake on circulating antigen-antibody complexes in patients with alcoholic liver cirrhosis. Digestion. 1978;17(6):554–559. doi: 10.1159/000198162. [DOI] [PubMed] [Google Scholar]
  2. Barnes R. M., Allan S., Taylor-Robinson C. H., Finn R., Johnson P. M. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol. 1990;92(1):9–15. doi: 10.1159/000235217. [DOI] [PubMed] [Google Scholar]
  3. Barnes R. M., Johnson P. M., Harvey M. M., Blears J., Finn R. Human serum antibodies reactive with dietary proteins. IgG subclass distribution. Int Arch Allergy Appl Immunol. 1988;87(2):184–188. doi: 10.1159/000234670. [DOI] [PubMed] [Google Scholar]
  4. Darroch C. J., Christmas S. E., Barnes R. M. In vitro human lymphocyte proliferative responses to a glycoprotein of the yeast Saccharomyces cerevisiae. Immunology. 1994 Feb;81(2):247–252. [PMC free article] [PubMed] [Google Scholar]
  5. Giaffer M. H., Clark A., Holdsworth C. D. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut. 1992 Aug;33(8):1071–1075. doi: 10.1136/gut.33.8.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  7. Heelan B. T., Allan S., Barnes R. M. Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. Immunol Lett. 1991 Jun;28(3):181–185. doi: 10.1016/0165-2478(91)90001-q. [DOI] [PubMed] [Google Scholar]
  8. Lerner A., Park B. H., Rossi T. M., Lebenthal E. Increased serum antibody levels against cow's milk proteins in children with chronic liver disease. Hepatology. 1985 May-Jun;5(3):488–491. doi: 10.1002/hep.1840050324. [DOI] [PubMed] [Google Scholar]
  9. Lindberg E., Magnusson K. E., Tysk C., Järnerot G. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut. 1992 Jul;33(7):909–913. doi: 10.1136/gut.33.7.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Main J., McKenzie H., Yeaman G. R., Kerr M. A., Robson D., Pennington C. R., Parratt D. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ. 1988 Oct 29;297(6656):1105–1106. doi: 10.1136/bmj.297.6656.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McKenzie H., Main J., Pennington C. R., Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut. 1990 May;31(5):536–538. doi: 10.1136/gut.31.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McKenzie H., Parratt D., Main J., Pennington C. R. Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. FEMS Microbiol Immunol. 1992 Apr;4(4):219–224. doi: 10.1111/j.1574-6968.1992.tb04997.x. [DOI] [PubMed] [Google Scholar]
  13. Riordan A. M., Hunter J. O., Cowan R. E., Crampton J. R., Davidson A. R., Dickinson R. J., Dronfield M. W., Fellows I. W., Hishon S., Kerrigan G. N. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet. 1993 Nov 6;342(8880):1131–1134. doi: 10.1016/0140-6736(93)92121-9. [DOI] [PubMed] [Google Scholar]
  14. Scott H., Fausa O., Ek J., Brandtzaeg P. Immune response patterns in coeliac disease. Serum antibodies to dietary antigens measured by an enzyme linked immunosorbent assay (ELISA). Clin Exp Immunol. 1984 Jul;57(1):25–32. [PMC free article] [PubMed] [Google Scholar]
  15. Sendid B., Colombel J. F., Jacquinot P. M., Faille C., Fruit J., Cortot A., Lucidarme D., Camus D., Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol. 1996 Mar;3(2):219–226. doi: 10.1128/cdli.3.2.219-226.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tamura N., Suou T., Hirayama C. Anti-albumin antibodies in sera of patients with liver disease. Gastroenterol Jpn. 1982 Oct;17(5):469–475. doi: 10.1007/BF02774725. [DOI] [PubMed] [Google Scholar]
  17. Wight N., Scott B. B., Wright N. Dietary treatment of active Crohn's disease. BMJ. 1997 Feb 15;314(7079):454–455. doi: 10.1136/bmj.314.7079.454. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES